financetom
Business
financetom
/
Business
/
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
Dec 2, 2024 6:52 AM

LONDON (Reuters) -French payments group Worldline has attracted early stage takeover interest from private equity firms, as it grapples with a falling share price, profit warnings and leadership change, five people with knowledge of the matter said.

Bain Capital is among private equity firms that have been in the initial stages of evaluating a possible bid for Worldline, two of the people said.

The firm has spoken with advisers to consider different permutations of how a bid could be formulated for Worldline, whose shares have been trading near a record low, one of the people said. The conversations have taken place over recent weeks, a second person said.

Shares in Worldline, which had a market capitalisation of 1.88 billion euros ($1.98 billion) by Friday's close, rose 15% after the Reuters report.

A spokesperson for Bain declined to comment. Worldline said it did not comment on market rumours.

Bain has experience in the payments sector, holding a 10% stake in and a board seat on Italy's Nexi alongside peer Advent International. If Bain were to bid for Worldline it would have to consider what to do with its stake in Nexi, the first person said.

Deliberations are at an early stage and a formal offer is not certain, the people said, asking not to be identified because the talks are confidential.

Discussions about a potential deal come during a challenging period for Worldline. Its shares have fallen by 92% since July, 2021 when investor enthusiasm for payments companies peaked, after recording three profit warnings within a year.

The company has since pursued cost-cutting measures including selling its Mobility and e-Transactional Services (MTS) business and laying off 8% of its workforce, Reuters reported.

Any bid could pose challenges. Worldline shareholders may not want to sell out at a historically low price, some of the people said. Any bidder may need to win over state-owned investment bank Bpifrance, which is a top 10 shareholder in Worldline with a 5% stake, they added.

Credit Agricole also has a 7% stake in Worldline and partnership targeting merchants, which it may want to maintain, a fifth person familiar with the situation said. Bpifrance and Credit Agricole declined to comment.

The payments sector has been seeing increased dealmaking.

Private equity firm GTCR struck a deal to buy Worldpay, the Fidelity National Information Services Inc. unit handling card payments for businesses across the world, last year.

Brookfield is also in talks to buy Barclay's payments business, according to reports. The Canadian group also led a consortium to acquire Middle Eastern payments group Network International for $2.8 billion in 2023.

Worldline was spun out of French technology group Atos in 2014, and has grown through acquisitions including merchant acquirer Ingenico in 2020 for 7.8 billion euros. It has been competing against Nexi and other payments companies for assets.

($1 = 0.9518 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Therapeutics Insider Sold Shares Worth $5,359,005, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,359,005, According to a Recent SEC Filing
Mar 27, 2026
04:38 PM EDT, 03/27/2026 (MT Newswires) -- James Edgemond, CFO and Treasurer, on March 26, 2026, sold 10,000 shares in United Therapeutics ( UTHR ) for $5,359,005. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000163617826000004/xslF345X05/primarydocument.xml ...
United Therapeutics Insider Sold Shares Worth $5,090,216, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,090,216, According to a Recent SEC Filing
Mar 27, 2026
04:37 PM EDT, 03/27/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on March 26, 2026, sold 9,500 shares in United Therapeutics ( UTHR ) for $5,090,216. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,872 common shares of the company, with 40,513 shares held directly and 639,359 controlled indirectly. SEC...
Convenience store owner Yesway moves closer to public markets with US IPO filing
Convenience store owner Yesway moves closer to public markets with US IPO filing
Mar 27, 2026
By Arasu Kannagi Basil March 27 (Reuters) - Yesway revived its U.S. initial public offering on Friday, moving the private equity-backed convenience store owner closer to public markets. The Fort Worth, Texas-based company had been pursuing an IPO since 2021, but shelved the plans in late 2022 when economic uncertainty crushed the new listing markets. The filing comes as market...
PMGC Unit Amends License Deal With MOA Life Plus on Development Timelines
PMGC Unit Amends License Deal With MOA Life Plus on Development Timelines
Mar 27, 2026
04:41 PM EDT, 03/27/2026 (MT Newswires) -- PMGC ( ELAB ) said late Friday its NorthStrive Biosciences unit has entered into a third amendment to its license agreement with MOA Life Plus, a South Korean biotechnology company. The amendment revises the timing and key development milestones for EL-32 and EL-22 human clinical programs, aligning the schedule with the parties' research,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved